Explore
Validate
Learn
Western blot
ImmunocytochemistryAntibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN151732 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-DNA (Cytosine-5)-Methyltransferase 1 (DNMT1) antibody
- Antibody type
- Polyclonal
- Antigen
- This antibody was raised against the first 10 kDa of the N-terminus of the DNMT1protein.
- Description
- Serum
- Reactivity
- Human
- Host
- Rabbit
- Vial size
- 0.1 mL
- Storage
- 4°C
Submitted references Stage-specific alterations of DNA methyltransferase expression, DNA hypermethylation, and DNA hypomethylation during prostate cancer progression in the transgenic adenocarcinoma of mouse prostate model.
Direct interaction between DNMT1 and G9a coordinates DNA and histone methylation during replication.
DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene.
Collaborative spirit of histone deacetylases in regulating chromatin structure and gene expression.
Senescence and epigenetic dysregulation in cancer.
A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer.
An essential role for DNA methyltransferase DNMT3B in cancer cell survival.
DNMT1 and DNMT3b cooperate to silence genes in human cancer cells.
Morey Kinney SR, Smiraglia DJ, James SR, Moser MT, Foster BA, Karpf AR
Molecular cancer research : MCR 2008 Aug;6(8):1365-74
Molecular cancer research : MCR 2008 Aug;6(8):1365-74
Direct interaction between DNMT1 and G9a coordinates DNA and histone methylation during replication.
Estève PO, Chin HG, Smallwood A, Feehery GR, Gangisetty O, Karpf AR, Carey MF, Pradhan S
Genes & development 2006 Nov 15;20(22):3089-103
Genes & development 2006 Nov 15;20(22):3089-103
DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
Robert MF, Morin S, Beaulieu N, Gauthier F, Chute IC, Barsalou A, MacLeod AR
Nature genetics 2003 Jan;33(1):61-5
Nature genetics 2003 Jan;33(1):61-5
Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene.
Bachman KE, Park BH, Rhee I, Rajagopalan H, Herman JG, Baylin SB, Kinzler KW, Vogelstein B
Cancer cell 2003 Jan;3(1):89-95
Cancer cell 2003 Jan;3(1):89-95
Collaborative spirit of histone deacetylases in regulating chromatin structure and gene expression.
Yang XJ, Seto E
Current opinion in genetics & development 2003 Apr;13(2):143-53
Current opinion in genetics & development 2003 Apr;13(2):143-53
Senescence and epigenetic dysregulation in cancer.
Neumeister P, Albanese C, Balent B, Greally J, Pestell RG
The international journal of biochemistry & cell biology 2002 Nov;34(11):1475-90
The international journal of biochemistry & cell biology 2002 Nov;34(11):1475-90
A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer.
Suzuki H, Gabrielson E, Chen W, Anbazhagan R, van Engeland M, Weijenberg MP, Herman JG, Baylin SB
Nature genetics 2002 Jun;31(2):141-9
Nature genetics 2002 Jun;31(2):141-9
An essential role for DNA methyltransferase DNMT3B in cancer cell survival.
Beaulieu N, Morin S, Chute IC, Robert MF, Nguyen H, MacLeod AR
The Journal of biological chemistry 2002 Aug 2;277(31):28176-81
The Journal of biological chemistry 2002 Aug 2;277(31):28176-81
DNMT1 and DNMT3b cooperate to silence genes in human cancer cells.
Rhee I, Bachman KE, Park BH, Jair KW, Yen RW, Schuebel KE, Cui H, Feinberg AP, Lengauer C, Kinzler KW, Baylin SB, Vogelstein B
Nature 2002 Apr 4;416(6880):552-6
Nature 2002 Apr 4;416(6880):552-6
No comments: Submit comment
No validations: Submit validation data